Company Name, Ticker, Industry, else..

Caribou Biosciences Inc (NASDAQ: CRBU)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Caribou Biosciences Inc 's

Name: Caribou Biosciences Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CRBU Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Caribou Biosciences Inc reported Revenue decrease in the 2 quarter 2026 year on year by -43.79 %, despite the revenue increase by the most of its competitors of 128 %, recorded in the same quarter.

• List of CRBU Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Caribou Biosciences Inc recorded a net loss, as well as most of its competitors.

<< CRBU Stock Performance Comparisons

<< See the full list of CRBU competitors

Overall company Market Share Q2 2026

Overall company, revenue fell by -43.79 % and company lost market share, to approximately 0.18 %. << More on CRBU Market Share.

*Market share is calculated based on total revenue.

News about Caribou Biosciences Inc Contracts

Legal and Financial Crossroads Caribou Biosciences Strategic Dilemmas in a Competitive Landscape,

December 27, 2024
Navigating Tumultuous Waters: Caribou Biosciences Faces Legal and Financial ChallengesIn an unfolding saga that blends legal complexity with financial turbulence, Caribou Biosciences, Inc. (NASDAQ: CRBU) finds itself at a pivotal juncture. Known for its pioneering work in genome editing, the company is grappling with a dual-front battle: a significant class action lawsuit and a sharp decline in revenue as compared to its competitors. This article delves into the intricacies of these challenges and their implications for the company’s future. Legal Repercussions: The Class Action LawsuitOn December 27, 2024, Bronstein, Gewirtz and Grossman, LLC, a prominent law firm with expertise in investor rights, issue...

CRBU's Stock Performance relative to its Competitors

Publicly Traded Peers of Caribou Biosciences Inc

Vor Biopharma Inc
Share Performance

-28.57%

One Year

Vor Biopharma Inc

Profile

Vor Biopharma Inc's business model focuses on developing novel cell therapies for the treatment of cancer.

More about Vor Biopharma Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,218.049 mill.	$ - mill.	$ 627.779 mill.

Phoenix Biotech Acquisition Corp
Share Performance

0.00%

One Year

Phoenix Biotech Acquisition Corp

Profile

Phoenix Biotech Acquisition Corp is a company that focuses on acquiring and investing in biotech businesses.

More about Phoenix Biotech Acquisition Corp's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 437.355 mill.	$ - mill.	$ -44.738 mill.

Intellia Therapeutics Inc
Share Performance

-6.36%

One Year

Intellia Therapeutics Inc

Profile

Intellia Therapeutics Inc is a biotechnology company focused on developing therapies based on CRISPR/Cas9 gene editing technology.

More about Intellia Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,533.685 mill.	$ 59.506 mill.	$ -399.975 mill.

Metagenomi Therapeutics Inc
Share Performance

-36.61%

One Year

Metagenomi Therapeutics Inc

Profile

The company conducts research and development in genome editing technology and clinical trials.

More about Metagenomi Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 43.684 mill.	$ - mill.	$ -93.462 mill.

Meiragtx Holdings Plc
Share Performance

+30.42%

This Quarter

Meiragtx Holdings Plc

Profile

MeiraGTx Holdings Plc is a biotechnology company focused on developing gene therapies for inherited and acquired diseases. They leverage their proprietary technology to develop and commercialize innovative treatments that address unmet medical needs.

More about Meiragtx Holdings Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,174.442 mill.	$ 397.501 mill.	$ 78.931 mill.

38 more competitors available

Sources: Caribou Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:37 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Caribou Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.